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Recent publications have demonstrated the feasibility 
and utility of sequencing DNA or RNA from single cells 
[1,2]. Th e power of these tools lies in their ability to reveal 
in mixtures of cells the identity and state of sub­
populations. Th e advantage of single­cell analysis over 
merely deep sequencing, whether for DNA or RNA, lies 
in the ability of the former to isolate diff erences and to 
phase possibly multiple diff erences within subpopu la­
tions. Th e future applications of these technologies are 
the topic of this brief article.
I will assume throughout that in the near future assess­
ing both DNA and RNA content simultaneously from 
hundreds to thousands of single cells will be quanti­
tatively accurate, as complete as needed, and aff ordable. 
It follows from these assumptions that knowledge of 
chromatin confi guration and DNA methylation in single 
cells will also be attainable. I will not consider what is 
possible by assaying the protein content of single cells, 
either by microscopy or mass spectroscopy, or by using 
methods not yet invented. Also, I will not focus on the 
many applications of this technology in oncology, such as 
in outcome research and early detection, as these appli­
ca tions are ongoing and have been widely discussed else­
where [3]. Instead, I want to speculate on basic applica­
tions to cell biology, theory of disease and diagnosis.
Basic cell and organismal biology
Much of what we know about cell biology is derived from 
perturbation experiments. An agent ­ physical, chemical 
or genetic ­ acts upon a cell and elicits a sequence of 
reactions, whether metabolic, molecular or structural. 
Unless this response is monitored by microscopy or some 
other method for observing single cells, the response is 
measured in a population of cells. Even superfi cially 
homogeneous populations contain cells in diff erent 
phases of the cell cycle, or that have stochastic variance, 
and thus may diff er in response to a perturbing agent. 
Th e temporal chain of reactions is often muddied.
High­throughput single­cell nucleic acid analysis closes 
this gap, allowing the analysis of many single cells in a 
population, each responding to the perturbation. Each 
cell is a snapshot in the temporal chain of events, so 
mathematical and statistical methods are needed to piece 
together the response pathways [4]. Such analysis can 
reveal the causal linkage between events that were merely 
correlated before. Examples of potential applications 
abound, including studying the cellular response to DNA 
damage, hormones, contact with another cell, release 
from nutrient limitation and so forth.
In addition, the application of single cell genomic 
analysis should enable a clearer assessment of the nature 
of regulatory control. How tightly regulated are RNA 
levels from cell to cell? Is RNA expression (amount and 
splicing) monoallelic [5]? Because ­ under the assump­
tions outlined above  ­ chromatin confi guration and 
DNA methylation from single cells will also be 
attainable, we can anticipate being able to distinguish 
cause and eff ect when both transcription and chromatin 
change.
Any organ is made up of subpopulations of cell types, 
such as the various components of the blood, endothelial 
cells, stem cells and their descendants with varying 
degrees of functional specialization. Th ere is not a 
complete set of markers identifying all the population 
subtypes. Clustering single­cell RNA profi les is likely to 
yield a deeper recognition of cell types and to arm us 
with new tools for recognizing these cells. Most 
important among these are markers for stem cells and 
armed with such markers, single­cell analysis does allow 
the inspection of rare subpopulations [2].
For a cell of known type, we can also speak of its ‘state’. 
Cells of the same type may vary in state as they react to 
soluble factors, neighboring cells or synaptic inputs, 
transit through the cell cycle, and so on. In many of these 
cases, the state of the cell may be recognized from the 
expression profi le, and moreover the state may help us 
recognize which infl uences are acting on the cell. Th us, 
single­cell methods can be applied to such diverse 
problems as detecting the state of the stem cells in a given 
organ or understanding the transcriptional reaction of 
neurons to stimuli.© 2010 BioMed Central Ltd
Broad applications of single-cell nucleic acid 
analysis in biomedical research
Michael Wigler*
M U S I N G S
*Correspondence: wigler@cshl.edu
Cold Spring Harbor Laboratory, PO Box 100, Cold Spring Harbor, NY, 11724, USA
Wigler Genome Medicine 2012, 4:79 
http://genomemedicine.com/content/4/10/79
© 2012 BioMed Central Ltd
Pathobiology and diagnosis
Once armed with expectations about the normal state of 
tissues, we can use these expectations to investigate 
various disorders, such as diabetes and cancer. For 
example, in the latter, one can assess the cell types of host 
stroma, and their potential functions at the tumor site. 
Less obvious is the opportunity to analyze the basis of the 
medical disorders that result from the dysfunction of 
stem cells. Although speculative, it is likely that acquired 
problems of stem cells lie at the heart of many disorders 
of aging. These acquired problems can result from loss of 
DNA methylation or other epigenetic markers, and/or 
from accumulated somatic mutation such as loss of 
hetero zygosity that can unmask existing genetic vulnera­
bilities. Acquired autoimmunity, psoriasis or degenerative 
conditions, such as amyotrophic lateral sclerosis may be 
examples. Using single­cell methods, and our ability to 
distinguish cell types by their expression patterns, it 
should be possible to directly search for the presence of 
pathogenic somatic mutations in subtypes of dysfunc­
tional tissues.
In the future many tissue assays could be performed by 
single­cell methods, minimizing the necessary sample 
size and thereby lessening the stress of the biopsy 
procedure on the patient. The opportunities for cancer 
diagnosis from biopsies or fluid samples are clear. The 
most extreme example is pre­implantation genetic 
screen ing, where an assay of a single cell might guide 
embryo selection. A less obvious but broader set of 
diagnostics could be based on analysis of blood cells. The 
blood is the highway of the body, and it is likely that the 
cells that traffic there reflect specific defense and repair 
functions, as well as hints of proliferative disorders. For 
example, the state of immune cells might reflect the type 
of invading pathogen that the body is fighting, and 
damage to a particular organ might be reflected in the 
type of stem cell that is being recruited from the marrow. 
Learning to interpret the state and identity of cells in the 
blood from the RNAs they produce should be seen as a 
logical next step in the progression of blood­based 
clinical testing.
Clearly, there is far more to a cell than its DNA and 
RNA content. Nevertheless, high­throughput single­cell 
nucleic analysis has many applications to basic bio medi cal 
research. In time, these methods will alter medical care 
by maximizing the utility of minimal biopsy samples, and 
thereby improving treatment with earlier diagnosis using 
less invasive procedures.
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